Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 930 Neoplasms 708 Prostatic Neoplasms 490 Lung Neoplasms 398 Carcinoma, Non-Small-Cell Lung 359 Colorectal Neoplasms 357 Leukemia, Myeloid, Acute 290 Pancreatic Neoplasms 238 Brain Neoplasms 227 Neoplasm Metastasis 221 Multiple Myeloma 214 Carcinoma, Hepatocellular 199 Head and Neck Neoplasms 182 Glioblastoma 181 Precursor Cell Lymphoblastic Leukemia-Lymphoma 177 Melanoma 173 Ovarian Neoplasms 168 Squamous Cell Carcinoma of Head and Neck 160 Uterine Cervical Neoplasms 144 Rectal Neoplasms 144 Recurrence 142 Hematologic Neoplasms 134 Sarcoma 133 Triple Negative Breast Neoplasms 127 Stomach Neoplasms 127 Glioma 126 Carcinoma, Renal Cell 123 Colonic Neoplasms 113 Myelodysplastic Syndromes 112 Urinary Bladder Neoplasms 109

Interventions

ribociclib 1 Letrozole 1 Goserelin 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × HER2 Negative Breast Cancer × 90 days × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡